Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bedranol SR 80mg capsules (Sandoz)
0204000R0BDADAA
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 2,381 |
|
Bedranol SR 80mg capsules (Almus)
0204000R0BDAFAA
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 612 |
|
Bedranol SR 160mg capsules (Sandoz)
0204000R0BDACAB
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 473 |
|
Bedranol SR 160mg capsules (Almus)
0204000R0BDAEAB
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 59 |
|
Bedranol 40mg tablets
0204000R0BDAIAJ
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 34 |
|
Bedranol 80mg tablets
0204000R0BDAJAK
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 9 |
|
Bedranol 10mg tablets
0204000R0BDAGAH
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 5 |
|
Bedranol 160mg tablets
0204000R0BDAHAL
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.